Saccharomyces cerevisiae β-glucan improves the response of trained macrophages to severe P. aeruginosa infections.

Saccharomyces cerevisiae β-glucan Biofilm P. Aeruginosa Inflammation Trained macrophages

Journal

Inflammation research : official journal of the European Histamine Research Society ... [et al.]
ISSN: 1420-908X
Titre abrégé: Inflamm Res
Pays: Switzerland
ID NLM: 9508160

Informations de publication

Date de publication:
08 Jun 2024
Historique:
received: 12 01 2024
accepted: 27 05 2024
revised: 15 05 2024
medline: 8 6 2024
pubmed: 8 6 2024
entrez: 8 6 2024
Statut: aheadofprint

Résumé

OBJECTIVE P. AERUGINOSA: (PA), the major pathogen of lung cystic fibrosis (CF), polarizes macrophages into hyperinflammatory tissue damaging phenotype. The main aim of this study was to verify whether training of macrophages with β-glucan might improve their response to P. aeruginosa infections. To perform this task C57BL/6 mice sensitive to infections with P. aeruginosa were used. Peritoneal macrophages were trained with Saccharomyces cerevisiae β-glucan and exposed to PA57, the strong biofilm-forming bacterial strain isolated from the patient with severe lung CF. The release of cytokines and the expression of macrophage phenotypic markers were measured. A quantitative proteomic approach was used for the characterization of proteome-wide changes in macrophages. The effect of in vivo β-glucan-trained macrophages in the air pouch model of PA57 infection was investigated. In all experiments the effect of trained and naïve macrophages was compared. Trained macrophages acquired a specific phenotype with mixed pro-inflammatory and pro-resolution characteristics, however they retained anti-bacterial properties. Most importantly, transfer of trained macrophages into infected air pouches markedly ameliorated the course of infection. PA57 bacterial growth and formation of biofilm were significantly suppressed. The level of serum amyloid A (SAA), a systemic inflammation biomarker, was reduced. Training of murine macrophages with S. cerevisiae β-glucan improved macrophage defense properties along with inhibition of secretion of some detrimental inflammatory agents. We suggest that training of macrophages with such β-glucans might be a new therapeutic strategy in P. aeruginosa biofilm infections, including CF, to promote eradication of pathogens and resolution of inflammation.

Identifiants

pubmed: 38850343
doi: 10.1007/s00011-024-01898-1
pii: 10.1007/s00011-024-01898-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respirat Rev. 2002;3(2):128–34. https://doi.org/10.1016/S1526-0550(02)00003-3 .
doi: 10.1016/S1526-0550(02)00003-3
Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, et al. Alveolar inflammation in cystic fibrosis. J Cyst Fibros. 2010;9(3):217–27. https://doi.org/10.1016/j.jcf.2010.03.001 .
doi: 10.1016/j.jcf.2010.03.001 pubmed: 20347403 pmcid: 2883667
Allard B, Panariti A, Martin JG. Alveolar macrophages in the resolution of inflammation, tissue repair, and tolerance to infection. 2018;9. https://doi.org/10.3389/fimmu.2018.01777 .
Ciszek-Lenda M, Strus M, Walczewska M, Majka G, Machul-Żwirbla A, Mikołajczyk D, et al. Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation. Inflamm Res. 2019;68(5):397–413. https://doi.org/10.1007/s00011-019-01227-x .
doi: 10.1007/s00011-019-01227-x pubmed: 30887082 pmcid: 6450861
Bruscia EM, Bonfield TL. Cystic fibrosis lung immunity: the role of the macrophage. J Innate Immun. 2016;8(6):550–63. https://doi.org/10.1159/000446825 .
doi: 10.1159/000446825 pubmed: 27336915 pmcid: 5089923
Bekkering S, Blok BA, Joosten LAB, Riksen NP, Crevel Rv, Netea MG. Vitro Experimental Model of trained Innate. Immun Hum Prim Monocytes. 2016;23(12):926–33. https://doi.org/10.1128/CVI.00349-16 .
doi: 10.1128/CVI.00349-16
van der Meer JWM, Joosten LAB, Riksen N, Netea MG. Trained immunity: a smart way to enhance innate immune defence. Mol Immun. 2015;68(1):40–4. https://doi.org/10.1016/j.molimm.2015.06.019 .
doi: 10.1016/j.molimm.2015.06.019
Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe. 2012;12(2):223–32. https://doi.org/10.1016/j.chom.2012.06.006 .
doi: 10.1016/j.chom.2012.06.006 pubmed: 22901542
Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78(922):455–9. https://doi.org/10.1136/pmj.78.922 . .455%J Postgrad Med J.
doi: 10.1136/pmj.78.922 pubmed: 12185216 pmcid: 1742467
Xu X, Yasuda M, Mizuno M, Ashida H. β-Glucan from Saccharomyces cerevisiae reduces lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. Biochim Biophys Acta. 2012;1820(10):1656–63. https://doi.org/10.1016/j.bbagen.2012.06.015 .
doi: 10.1016/j.bbagen.2012.06.015 pubmed: 22750202
Fakruddin M, Hossain MN, Ahmed MM. Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complement Alternat Med. 2017;17(1):64. https://doi.org/10.1186/s12906-017-1591-9 .
doi: 10.1186/s12906-017-1591-9
Sapru K, Stotland PK, Stevenson MM. Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and -susceptible mice. Clin Exp Immun. 2001;115(1):103–9. https://doi.org/10.1046/j.1365-2249.1999.00762.x .
doi: 10.1046/j.1365-2249.1999.00762.x
Majka G, Mazurek H, Strus M, Ciszek-Lenda M, Szatanek R, Pac A, et al. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6. Clin Exp Immun. 2021;205(3):391–405. https://doi.org/10.1111/cei.13624 .
doi: 10.1111/cei.13624 pubmed: 34031873 pmcid: 8374217
Leonhardt J, Große S, Marx C, Siwczak F, Stengel S, Bruns T et al. Candida albicans β-Glucan differentiates human monocytes into a specific subset of macrophages. 2018;9. https://doi.org/10.3389/fimmu.2018.02818 .
McCarson KE, Fehrenbacher JC. Models of Inflammation: Carrageenan- or Complete Freund’s Adjuvant (CFA)–Induced Edema and Hypersensitivity in the Rat. 2021;1(7):e202. https://doi.org/10.1002/cpz1.202 .
Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immun. 1988;141(7):2407–12. https://doi.org/10.4049/jimmunol.141.7.2407 .
doi: 10.4049/jimmunol.141.7.2407 pubmed: 3139757
Ciszek-Lenda M, Majka G, Suski M, Walczewska M, Górska S, Golińska E, et al. Biofilm-forming strains of P. Aeruginosa and S. Aureus isolated from cystic fibrosis patients differently affect inflammatory phenotype of macrophages. Inflamm Res. 2023;72(6):1275–89. https://doi.org/10.1007/s00011-023-01743-x .
doi: 10.1007/s00011-023-01743-x pubmed: 37253897 pmcid: 10279583
Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359–62. https://doi.org/10.1038/nmeth.1322 .
doi: 10.1038/nmeth.1322 pubmed: 19377485
Wiśniewski JR, Gaugaz FZ. Fast and sensitive total protein and peptide assays for proteomic analysis. Anal Chem. 2015;87(8):4110–6. https://doi.org/10.1021/ac504689z .
doi: 10.1021/ac504689z pubmed: 25837572
Bruderer R, Bernhardt OM, Gandhi T, Miladinović SM, Cheng L-Y, Messner S, et al. Extending the limits of quantitative proteome profiling with Data-Independent Acquisition and application to acetaminophen-treated three-Dimensional Liver microtissues. Mol Cell Proteom. 2015;14(5):1400–10. https://doi.org/10.1074/mcp.M114.044305 .
doi: 10.1074/mcp.M114.044305
Storey JD. A direct approach to false discovery rates. J Royal Stat Society: Ser B (Statistical Methodology). 2002;64(3):479–98. https://doi.org/10.1111/1467-9868.00346 .
doi: 10.1111/1467-9868.00346
Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–6. https://doi.org/10.1038/nbt.2839 .
doi: 10.1038/nbt.2839 pubmed: 24727771 pmcid: 3986813
Peruń A, Biedroń R, Konopiński MK, Białecka A, Marcinkiewicz J, Józefowski S. Phagocytosis of live versus killed or fluorescently labeled bacteria by macrophages differ in both magnitude and receptor specificity. 2017;95(5):424–35. https://doi.org/10.1038/icb.2016.112 .
Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090. https://doi.org/10.1016/j.ejphar.2020.173090 .
doi: 10.1016/j.ejphar.2020.173090 pubmed: 32234529
Simonin-Le Jeune K, Le Jeune A, Jouneau S, Belleguic C, Roux P-F, Jaguin M, et al. Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, Inflammtory cytokines increase. PLoS ONE. 2013;8(9):e75667. https://doi.org/10.1371/journal.pone.0075667 .
doi: 10.1371/journal.pone.0075667 pubmed: 24098711 pmcid: 3787056
Pernet E, Prevel R, Divangahi M. Training can’t always lead to Olympic macrophages. J Clin Invest. 2022;132(7). https://doi.org/10.1172/jci158468 .
Hashimoto T, Ohno N, Adachi Y, Yadomae T. Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol Med Microbiol. 1997;19(2):131–5. https://doi.org/10.1111/j.1574-695X.1997.tb01082.x .
doi: 10.1111/j.1574-695X.1997.tb01082.x pubmed: 9395058
Municio C, Alvarez Y, Montero O, Hugo E, Rodríguez M, Domingo E, et al. The response of human macrophages to β-Glucans depends on the inflammatory milieu. PLoS ONE. 2013;8(4):e62016. https://doi.org/10.1371/journal.pone.0062016 .
doi: 10.1371/journal.pone.0062016 pubmed: 23637950 pmcid: 3634770
Rizzetto L, Ifrim DC, Moretti S, et al. Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae. J Biol Chem. 2016;291(15):7961–72. https://doi.org/10.1074/jbc.M115.699645 .
doi: 10.1074/jbc.M115.699645 pubmed: 26887946 pmcid: 4825003
Vuscan P, Kischkel B, Joosten LAB, Netea MG. Trained immunity: General and emerging concepts. Immunol Rev. 2024. https://doi.org/10.1111/imr.13326 .
doi: 10.1111/imr.13326 pubmed: 38551324
Shea-Donohue T, Zhao A, Antalis TM. SerpinB2 mediated regulation of macrophage function during enteric infection. Gut Microbes. 2014;5(2):254–8. https://doi.org/10.4161/gmic.28093 .
doi: 10.4161/gmic.28093 pubmed: 24637799 pmcid: 4063854
Vandooren J, Goeminne P, Boon L, Ugarte-Berzal E, Rybakin V, Proost P et al. Neutrophils and activated macrophages Control Mucosal immunity by Proteolytic Cleavage of Antileukoproteinase. 2018;9. https://doi.org/10.3389/fimmu.2018.01154 .
Holley AK, Bakthavatchalu V, Velez-Roman JM. St. Clair DK. Manganese Superoxide Dismutase: Guardian Powerhouse. 2011;12(10):7114–62.
Gaggar A, Hector A, Bratcher PE, Mall MA, Griese M, Hartl D. The role of matrix metalloproteinases in cystic fibrosis lung disease. 2011;38(3):721–7. https://doi.org/10.1183/09031936.00173210 .
De Groote MA, Fang FC. NO inhibitions: Antimicrobial properties of nitric oxide. Clin Infect Dis. 1995;21(Supplement2):S162–5. https://doi.org/10.1093/clinids/21.Supplement_2.S162 .
doi: 10.1093/clinids/21.Supplement_2.S162 pubmed: 8845445
Fischer A, Rausell A. Primary immunodeficiencies suggest redundancy within the human immune system. 2016;1(6):eaah5861. doi: https://doi.org/10.1126/sciimmunol.aah5861 .
Shah C, Hari-Dass R, Raynes JG. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood. 2006;108(5):1751–7. https://doi.org/10.1182/blood-2005-11-011932 .
doi: 10.1182/blood-2005-11-011932 pubmed: 16735604
Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta (BBA) –. Rev Cancer. 2012;1826(1):129–69. https://doi.org/10.1016/j.bbcan.2012.03.008 .
doi: 10.1016/j.bbcan.2012.03.008
Hirano M, Davis RS, Fine WD, Nakamura S, Shimizu K, Yagi H, et al. IgEb immune complexes activate macrophages through FcgammaRIV binding. Nat Immun. 2007;8(7):762–71. https://doi.org/10.1038/ni1477 .
doi: 10.1038/ni1477
Wang L, Wu D, Robinson CV, Wu H, Fu TM. Structures of a complete human V-ATPase reveal mechanisms of its Assembly. Mol Cell. 2020;80(3):501–e113. https://doi.org/10.1016/j.molcel.2020.09.029 .
doi: 10.1016/j.molcel.2020.09.029 pubmed: 33065002 pmcid: 7655608
Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med. 2003;198(8):1277–83. https://doi.org/10.1084/jem.20030705 .
doi: 10.1084/jem.20030705 pubmed: 14568985 pmcid: 2194231
Xu X, Yasuda M, Mizuno M, Ashida H. beta glucan from Saccharomyces cerevisiae reduces lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. Biochim Biophys Acta. 2012;1820(10):1656–63. https://doi.org/10.1016/j.bbagen.2012.06.015 .
doi: 10.1016/j.bbagen.2012.06.015 pubmed: 22750202
Vodovotz Y, Bogdan C, Paik Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med., Yang X, Li S, Zhao Y, Li S, Zhao T, Tai Y et al. GRK2 Mediated Abnormal Transduction of PGE2-EP4-cAMP-CREB Signaling Induces the Imbalance of Macrophages Polarization in Collagen-Induced Arthritis Mice. 2019;8(12):1596.
Tsuge K, Inazumi T, Shimamoto A, Sugimoto Y. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. Int Immun. 2019;31(9):597–606. https://doi.org/10.1093/intimm/dxz021 International Immunology.
Yamauchi K, Kasuya Y, Kuroda F, Tanaka K, Tsuyusaki J, Ishizaki S, et al. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res. 2011;12(1):131. https://doi.org/10.1186/1465-9921-12-131 .
doi: 10.1186/1465-9921-12-131 pubmed: 21970554 pmcid: 3198935

Auteurs

Marta Ciszek-Lenda (M)

Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Bernadeta Nowak (B)

Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Grzegorz Majka (G)

Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland. grzegorz.majka@uj.edu.pl.

Maciej Suski (M)

Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Grzegorzecka 16, Krakow, 31-53, Poland.

Maria Walczewska (M)

Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Angelika Fedor (A)

Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Edyta Golińska (E)

Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Sabina Górska (S)

Hirszfeld Institute of Immunology and Experimental Therapy, Department of Microbiology, Laboratory of Microbiome Immunobiology, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland.

Andrzej Gamian (A)

Hirszfeld Institute of Immunology and Experimental Therapy, Department of Immunology of Infectious Diseases, Laboratory of Medical Microbiology, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland.

Rafał Olszanecki (R)

Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Grzegorzecka 16, Krakow, 31-53, Poland.

Magdalena Strus (M)

Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18, Krakow, 31-121, Poland.

Janusz Marcinkiewicz (J)

University of Agriculture, University Centre of Veterinary Medicine, Mickiewicza 24/28, Krakow, 30- 059, Poland.

Classifications MeSH